Brief: Pixium Vision in discussion with FDA for a feasibility study with its PRIMA System
13/06/2017 06:01
June 13 (Reuters) - PIXIUM VISION SA PIX.PA :
* PIXIUM VISION ADVANCES IN DISCUSSIONS WITH FDA FOR A FEASIBILITY STUDY WITH ITS PRIMA
SYSTEM FOR DRY-AMD
* CLINICAL EVALUATION OF PRIMA BEING ASSESSED FOR EARLY FEASIBILITY STUDY PROGRAM IN US
* EARLY FEASIBILITY STUDY MAY BE PURSUED FOR PATIENTS SUFFERING FROM ADVANCED DRY
AGE-RELATED MACULAR DEGENERATION
* AIMS FOR CLINICAL FEASIBILITY STUDY IN HUMAN WITHIN 2017
Source text for Eikon: ID:nBw2xfHVHa
Further company coverage: PIX.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Pixium Vision SA
See all newsBrief: Pixium Vision SA Says Paris Commercial Court Postponed Decision On Takeover Offer Filed On Nov 20, 2023
Brief: Pixium Vision: opening of judicial liquidation proceedings has been postponed to later date
Brief: Pixium Vision Announces Decision About Adoption Of Sale Plan, Opening Of Judicial Liquidation Proceedings Planned For Jan 16, 2024
Brief: Pixium Vision SA Announces Conversion Of Safeguard Proceedings Into Receivership
Brief: Pixium Vision Announces Tender Process For Purpose Of Finding Buyers To Acquire Company's Business Will Be Published Tomorrow